You Said It: Reader Feedback
The following stories got
TheStreet
readers talking Wednesday:
New Study Cites Cancer Risk of Cell Phones
A new study and upcoming conference are resurrecting the debate over whether cell phone user is tied to cancer.
Rich Foreigners Buy U.S. Homes: Unreal Estate
Rich property investors from abroad are taking advantage of low prices and sluggish sales in the U.S.
Steer Clear of Palm, Sirius: Analyst's Toolkit
Palm
(PALM)
and
Sirius
(SIRI) - Get Report
shares are soaring, but their enterprise multiples suggest there are better values to be had in technology.
FDA Panel Recommends Approval for Allos Cancer Drug: BioBuzz
The FDA's cancer drug advisory panel voted 10-4 to recommend approval of Allos Therapeutics'
(ALTH)
lymphoma drug pralatrexate.
Wells Fargo in the Crosshairs Again
Wells Fargo
(WFC) - Get Report
will be in the spotlight on Wednesday, as investors consider whether the firm can earn its way out of the federal bailout and credit woes.
Follow TheStreet.com on
and become a fan on
This article was written by a staff member of TheStreet.com.
